Slowikowska Malwina, Bajzert Joanna, Miller Julia, Stefaniak Tadeusz, Niedzwiedz Artur
Department of Internal Medicine and Clinic of Diseases of Horses, Dogs and Cats, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, 50-366 Wroclaw, Poland.
Department of Immunology, Pathophysiology and Veterinary Preventive Medicine, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland.
Animals (Basel). 2021 Apr 2;11(4):1001. doi: 10.3390/ani11041001.
Non-invasive diagnostic biomarkers of equine asthma syndrome (EAS) from blood or urine are sought. The aim of this study was to assess the absorbance of circulating immune complexes (CICs) during the exacerbation, remission, and treatment of an asthma episode and assess the potential usefulness of CIC levels in the diagnosis and monitoring of the disease. The control group, asthma group, and treated asthma group each contained six horses. Following an initial examination and group classification, the horses were kept in a dusty environment for seven days and then moved to an asthma-friendly environment for three weeks (the treated group received injections of glucocorticoids). Blood was collected at baseline and on the 1st, 2nd, 3rd, 7th, 14th and 30th days. CIC was measured using the modified Haskova method. The time points did not show significant statistical differences. There was a significant decrease in CIC in the treated group, and a significant increase in CIC in the non-treated group on day 30. CIC did not support the EAS diagnosis, although it may help in monitoring patients. To the best of the authors' knowledge, this is the first study to analyse the dynamics of CIC during environmental challenge, remission, and treatment.
人们正在寻找来自血液或尿液的马哮喘综合征(EAS)的非侵入性诊断生物标志物。本研究的目的是评估哮喘发作的加重期、缓解期和治疗期循环免疫复合物(CIC)的吸光度,并评估CIC水平在该疾病诊断和监测中的潜在用途。对照组、哮喘组和治疗后的哮喘组每组包含6匹马。在进行初步检查和分组后,将马匹置于多尘环境中7天,然后转移到有利于哮喘恢复的环境中3周(治疗组接受糖皮质激素注射)。在基线以及第1、2、3、7、14和30天采集血液。使用改良的哈斯科娃方法测量CIC。各时间点未显示出显著的统计学差异。治疗组的CIC在第30天显著下降,未治疗组的CIC在第30天显著增加。CIC不支持EAS诊断,尽管它可能有助于监测患者。据作者所知,这是第一项分析环境激发、缓解和治疗期间CIC动态变化的研究。